The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of pembrolizumab in EGFR-mutant, PD-L1+, tyrosine kinase inhibitor (TKI) naïve patients with advanced NSCLC.
 
Aaron Elliott Lisberg
Employment - Boston Scientific (I)
Stock and Other Ownership Interests - Boston Scientific (I)
Consulting or Advisory Role - AstraZeneca
 
Amy Lauren Cummings
No Relationships to Disclose
 
Jonathan Wade Goldman
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; Genentech/Roche; Lilly; Trovagene; Vortex Biosciences
Speakers' Bureau - Merck
Research Funding - Abbvie; Array BioPharma; Astellas Pharma; Astex Pharmaceuticals; AstraZeneca/MedImmune; Bristol-Myers Squibb; Celgene; Clovis Oncology; Corvus Pharmaceuticals; Genentech/Roche; Lilly; Threshold Pharmaceuticals
 
Krikor Bornazyan
No Relationships to Disclose
 
Nicholas Dean Reese
Employment - Allergan (I)
Stock and Other Ownership Interests - Allergan (I)
 
Tina Wang
No Relationships to Disclose
 
Paul Coluzzi
No Relationships to Disclose
 
Blanca A. Ledezma
No Relationships to Disclose
 
Melody A. Mendenhall
Speakers' Bureau - Merck
 
Benjamin Jones
No Relationships to Disclose
 
John Madrigal
No Relationships to Disclose
 
James M. Carroll
No Relationships to Disclose
 
Jaklin Gukasyan
No Relationships to Disclose
 
Tawny Williams
No Relationships to Disclose
 
Lauren Sauer
No Relationships to Disclose
 
Courtney L Wells
No Relationships to Disclose
 
Ariana R Hardy
No Relationships to Disclose
 
Paulina J Linares
No Relationships to Disclose
 
Carlos R. Adame
No Relationships to Disclose
 
Edward B. Garon
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Lilly (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst)